InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（10 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
10
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Tahir Misbah, 首席财务官. Insider active across 1 company, notably IGM Biosciences, Inc.. In total, 23 disclosures have been published. Breakdown: 0 buy · 10 sells. Total volume traded: €156k. History available since 14 May 2021. The latest transaction was filed on 23 July 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Tahir Misbah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
8,741 股@ US$1.27285.3% 占其流量Common StockSEC:0001415889-25-020311:0
1,522 股@ US$1.19920.9% 占其流量Common StockSEC:0001415889-25-017915:0
7,329 股@ US$1.234.8% 占其流量Common StockSEC:0001415889-25-008520:0
1,708 股@ US$7.487.1% 占其流量Common StockSEC:0001415889-24-029775:0
66,667 股0Common StockSEC:0001415889-24-027363:0
1,487 股@ US$11.53889.0% 占其流量Common StockSEC:0001415889-24-023586:0
33,111 股Common StockSEC:0001415889-24-020004:0
1,570 股@ US$7.57536.4% 占其流量Common StockSEC:0001415889-24-017499:0
2,897 股@ US$9.875215.2% 占其流量Common StockSEC:0001415889-24-008169:0
46,250 股0Common StockSEC:0001415889-24-008054:0
234 股@ US$11.711.5% 占其流量Common StockSEC:0001209191-23-056944:0
398 股@ US$11.712.5% 占其流量Common StockSEC:0001209191-23-032305:0
26,250 股0Common StockSEC:0001209191-23-023702:0
1,768 股@ US$18.73217.9% 占其流量Common StockSEC:0001209191-23-019420:0
1,468 股@ US$18.774615.1% 占其流量Common StockSEC:0001209191-22-062260:0
353 股@ US$12.842.6% 占其流量Common StockSEC:0001209191-22-058912:0
950 股@ US$17.102649.0% 占其流量Common StockSEC:0001209191-22-032232:0
391 股@ US$12.3815.1% 占其流量Common StockSEC:0001209191-22-029859:0
6,084 股0Common StockSEC:0001209191-22-019760:0
12,500 股0Common StockSEC:0001209191-22-019013:0
10,000 股0Common StockSEC:0001209191-21-065986:0
86 股@ US$50.992.2% 占其流量Common StockSEC:0001209191-21-065259:0
45 股@ US$45.901.0% 占其流量Common StockSEC:0001209191-21-033861:0
23 条申报中的 23 条
About Tahir Misbah
Tahir Misbah is Chief Financial Officer at IGM Biosciences, Inc. He has 23 filings in total, and across the 23 sampled filings between 2021-05-18 and 2025-07-25, sell transactions total 156152 EUR and the most frequent transaction nature is Attribution.
